Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 8,720 shares at $50.14 ($442K) on 2020-12-07, disclosed to the SEC on 2020-12-09.
Open-market sale of $442k ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.79 | 780 | $38K | 8.6% |
| 2 | $50.14 | 3,000 | $150K | 34.1% |
| 3 | $51.26 | 2,470 | $127K | 28.7% |
| 4 | $51.26 | 2,470 | $127K | 28.7% |
| Total | $50.65 avg | 8,720 | $442K | 100% |
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-11-10 | $592K | — | Filing → |